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28 Abstract:
29 In order to sustain a persistent infection, Mycobacterium tuberculosis (Mtb) must adapt to a changing 
30 environment that is shaped by the developing immune response.  This necessity to adapt is evident in the 
31 flexibility of many aspects of Mtb metabolism, including a respiratory chain that consists of two distinct terminal 
32 cytochrome oxidase complexes.  Under the conditions tested thus far, the bc1/aa3 complex appears to play a 
33 dominant role, while the alternative bd oxidase is largely redundant.  However, presence of two terminal 
34 oxidases in this obligate pathogen implies that respiratory requirements might change during infection.  We 
35 report that the cytochrome bd oxidase is specifically required for resisting the adaptive immune response. 
36 While the bd oxidase was dispensable for growth in resting macrophages and the establishment of infection in 
37 mice, this complex was necessary for optimal fitness after the initiation of adaptive immunity.  This requirement 
38 was dependent on lymphocyte-derived interferon gamma (IFNγ), but did not involve nitrogen and oxygen 
39 radicals that are known to inhibit respiration in other contexts.  Instead, we found that ΔcydA mutants were 
40 hypersusceptible to the low pH encountered in IFNγ-activated macrophages.  Unlike wild type Mtb, cytochrome 
41 bd-deficient bacteria were unable to sustain a maximal oxygen consumption rate (OCR) at low pH, indicating 
42 that the remaining cytochrome bc1/aa3 complex is preferentially inhibited under acidic conditions.  Consistent 
43 with this model, the potency of the cytochrome bc1/aa3 inhibitor, Q203, is dramatically enhanced at low pH.  
44 This work identifies a critical interaction between host immunity and pathogen respiration that influences both 
45 the progression of the infection and the efficacy of potential new TB drugs. 
46
47 Author Summary:
48 Tuberculosis, caused by Mycobacterium tuberculosis (Mtb) is a serious global health problem that is 
49 responsible for over one million deaths annually, more than any other single infectious agent. In the host, Mtb 
50 can adapt to a wide variety of immunological and environmental pressures which is integral to its success as a 
51 pathogen. Accordingly, the respiratory capacity of Mtb is flexible. The electron transport chain of Mtb has two 
52 terminal oxidases, the cytochrome bc1/aa3 super complex and cytochrome bd, that contribute to the proton 
53 motive force and subsequent production of energy in the form of ATP. The bc1/aa3 super complex is required 
54 for optimal growth during infection but the role of cytochrome bd is unclear. Here we report that the cytochrome 
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55 bd oxidase is required for resisting the adaptive immune response, in particular, acidification of the phagosome 
56 induced by lymphocyte-derived IFNγ. We found that the cytochrome bd oxidase is specifically required under 
57 acidic conditions, where the bc1/aa3 complex is preferentially inhibited. Additionally, we show that acidic 
58 conditions increased the potency of Q203, a cytochrome bc1/aa3 inhibitor and candidate tuberculosis therapy. 
59 This work defines a new link between the host immune response and the respiratory requirements of Mtb that 
60 affects the potency of a potential new therapeutic. 
61 Introduction
62 Tuberculosis (TB) is responsible for an estimated 1.4 million deaths annually and remains one of the 
63 most deadly infectious diseases (1). The causative agent of TB, Mycobacterium tuberculosis (Mtb), is an 
64 obligate aerobe and relies on oxidative phosphorylation (OXPHOS) via the electron transport chain (ETC) and 
65 glycolysis for energy production. The mycobacterial ETC has two terminal oxidases, the cytochrome bc1/aa3 
66 super complex that is related to mitochondrial complex III and IV, and the cytochrome bd oxidase which is 
67 unique to prokaryotes. These terminal oxidases transfer electrons from the ETC to O2 and contribute to the 
68 proton motive force (PMF) gradient that powers the production of ATP by ATP synthase. In Mtb, cytochrome 
69 bc1/aa3 is required for optimal growth and persistence in macrophage and infection mouse models using both 
70 genetic (2) and chemical inhibition of the complex (3-5).  
71 In the absence of cytochrome bc1/aa3, electrons are rerouted through the cytochrome bd oxidase (6). 
72 The latter complex in Mtb is encoded in a single operon, cydABDC, which produces both the cydAB oxidase 
73 complex and cydDC, a putative ABC-transporter that has not been studied in Mtb, but is necessary for 
74 assembly of the cytochrome in Escherichia coli (7, 8). Genetic deletions in the cydABDC operon produce 
75 hyper-susceptibility to cytochrome bc1/aa3 inhibitors, demonstrating a partially-redundant role for the terminal 
76 oxidases (4, 6, 9). However, the specific role played by the cytochrome bd oxidase in Mtb remains unclear.  In 
77 E.coli, the cytochrome bd oxidase detoxifies peroxide radicals and maintains respiration under hypoxic 
78 conditions (10, 11).  Similarly, studies in the saprophyte, Mycobacterium smegmatis, show that cyd mutants 
79 are hyper-susceptible to peroxide stress and expression of the cydAB operon is induced in hypoxic conditions 
80 (12, 13).  While it is plausible that these properties contribute to Mtb fitness during infection, the role played by 
81 the cytochrome bd oxidase in the mouse model of TB remains unclear.  Some studies report no effect of 
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82 cydABDC mutation, while others describe a fitness defect at the later stages of infection (2, 4, 14).  Thus, while 
83 it is clear that the cytochrome bd oxidase is active in mycobacteria, the non-redundant role of this system 
84 during infection is unknown.
85 As an obligate aerobe it is likely that this flexible respiratory chain has evolved to adapt to changing 
86 oxygen gradients encountered during infection. During the initial days after infection of the lung, Mtb replicates 
87 in macrophages, but once these cells are stimulated by T cell-derived cytokines, they restrict Mtb growth. 
88 Although Mtb is exposed to a variety of host pressures during infection, the stressors associated with activation 
89 of the macrophage cause a number of specific alterations in the bacterial environment that may alter 
90 respiratory requirements. In particular, IFNγ induces antimicrobial responses in the macrophage, including the 
91 production of the known respiratory poison, nitric oxide (NO) (15) via nitric oxidase synthase 2 (Nos2). 
92 Additionally, inhibition of respiration alters the sensitivity of Salmonella to IFNγ-induced superoxide production 
93 via the NADPH-dependent phagocyte oxidase (Phox) system (16). Lastly, IFNγ promotes the maturation of the 
94 pathogen-containing vacuole, promoting both its acidification and fusion with more degradative compartments. 
95 The observation that cydAB expression peaks with the onset of the adaptive immune response in the mouse 
96 model of infection further suggests an association between T cell cytokines, such as IFNγ, and alterations in 
97 the respiratory requirements of Mtb (14). 
98 In this work, we investigated the interactions between macrophage activation and the mycobacterial 
99 respiratory chain. We report that cytochrome bd oxidase is specifically required for the bacillus to resist IFNγ-
100 induced macrophage function. In particular, cytochrome bd oxidase is necessary in acidic environments similar 
101 to those encountered in the phagosome of IFNγ activated macrophages. These compartments can reach pH 
102 levels as low as 4.5 (17, 18), which we show preferentially inhibits the function of cytochrome bc1/aa3 complex. 
103 The relative acid-resistance of the cytochrome bd oxidase explains its specific function in counteracting IFNγ-
104 dependent immunity. 
105 Results
106 ΔcydA mutant is susceptible to IFNγ-activation of macrophages independent of Nos2 and Phox 
107 To investigate the effects of macrophage activation state on the requirement for the cytochrome bd 
108 oxidase in Mtb, we constructed a ΔcydA deletion mutant in H37Rv (19). Consistent with previous studies, there 
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109 was no difference in growth between H37Rv and ΔcydA mutants in broth culture (2, 9) (Figure 1A). We 
110 compared the fitness of H37Rv and ΔcydA mutants in bone marrow-derived macrophages (BMDMs) from 
111 C57BL/6J (wildtype) mice. Initially, we used flow cytometry and fluorescent live/dead reporter strains of Mtb to 
112 estimate relative bacterial growth and viability.  The Mtb strains expressed a constitutively expressed GFP 
113 marker and an anhydrotetracycline (ATc)-inducible RFP marker. GFP intensity was used to estimate total 
114 infected cell number and ATc-induced RFP intensity served as a surrogate measure of viability and correlates 
115 with CFU (20). By these metrics, the growth and viability of H37Rv and the ΔcydA mutant were not appreciably 
116 different in unstimulated BMDMs (Figure 1B-C).  
117 In other bacterial systems, the cytochrome bd oxidase is important for resistance to NO and oxidative 
118 stress, which are major mediators of IFNγ-dependent antimicrobial activity (10, 21-23). To determine if IFNγ or 
119 these reactive species alter the requirement for ΔcydA, we stimulated BMDMs with IFNγ, and included cells 
120 from Nos2-/- and Cybb-/- mice which lack functional Nos2 and Phox systems, respectively. In wildtype BMDMs, 
121 addition of IFNγ significantly reduced the number of cells harboring live H37Rv and ΔcydA bacteria (Figure 
122 1B). IFNγ treatment had no effect on the viability of H37Rv in Nos2-/- BMDMs, indicating that IFNγ-mediated 
123 inhibition of H37Rv is primarily dependent on NO, consistent with previous studies (18, 22) (Figure 1B). In 
124 contrast, Nos2 and Cybb were not necessary for IFNγ to inhibit ΔcydA mutants (Figure 1B). 
125 These observations were confirmed by CFU enumeration (Figure 1C).  The magnitude of IFNγ-
126 dependent inhibition was smaller in the CFU assay than the flow cytometry study, likely reflecting increased 
127 sensitivity of the live/dead reporter for bacterial fitness.  Regardless, the CFU assay also showed that IFN͏γ 
128 treatment reduced the viability of H37Rv in a Nos2-dependent, Cybb-independent manner, whereas the 
129 suppression of ΔcydA mutants was independent of both mediators.  To verify that these mutant phenotypes 
130 were due to a lack of cydABDC function, we tested a ΔcydD mutant and found that it was similarly attenuated 
131 in IFNγ-stimulated Nos2-/- cells as the ΔcydA strain (Figure 1D).  Both of these mutants could be 
132 complemented in trans by expressing the cydABDC operon.  These observations indicated the cytochrome bd 
133 oxidase was necessary to resist an IFNγ-induced stress that is independent of Nos2 and Cybb.
134
135
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136 IFNγ but not iNOS or Phox is necessary for the attenuation of ΔcydA in mouse lungs
137 The interaction between IFNγ and ΔcydA was then assessed in the mouse model. To evaluate the 
138 relative fitness of the ΔcydA mutant we performed competition infections using a mixture of H37Rv:Kan and 
139 ΔcydA:Hyg. To test the importance of lymphocyte-derived IFNγ, the relative fitness of the ∆cydA mutant was 
140 assessed in wild type C57BL/6J mice and animals lacking adaptive immunity (Rag-/- ), IFNγ receptor (Ifngr-/-), 
141 Nos2 (Nos2-/-) and Phox (Cybb-/-) (Figure 2A). At each timepoint, lung homogenates were plated on kanamycin 
142 and hygromycin and CFU were enumerated to compare the fitness of H37Rv and ΔcydA (Figure 2B). On day 
143 15 post infection, before the onset of adaptive immunity, there was no significant difference in CFU between 
144 H37Rv and ΔcydA across all five mouse genotypes (Figure 2B). Once the adaptive response was established 
145 after 30 days of infection, we observed a significant decrease in ΔcydA lung CFU compared to H37Rv in 
146 wildtype, Nos2-/-, and Cybb -/- mice. However, there was no difference between ΔcydA and H37Rv lung CFU in 
147 Ifgr-/- and Rag-/- mice demonstrating that the attenuation of the ΔcydA strain is dependent on lymphocytes and 
148 IFNγ (Figure 2B). Complementation of the ΔcydA mutant with cydABDC rescued the fitness defect observed in 
149 the mutants at the 30-day timepoint in wildtype mice (Figure 2C). These observations were consistent with the 
150 ex vivo macrophage infections, both indicating that the IFNγ-dependent attenuation of ΔcydA is Nos2 and 
151 Phox independent. 
152 ΔcydA mutants are defective for growth at low pH 
153 Beyond stimulating the production of RNS and ROS in macrophages, IFNγ also promotes the 
154 maturation and acidification of the mycobacterial phagosome.  To determine if the hyper-susceptibility of 
155 ΔcydA to IFNγ could be due to this reduction in pH, we investigated the fitness of ΔcydA mutants under acidic 
156 conditions. H37Rv and ΔcydA were grown in modified 7H9 media at pH values that span those encountered in 
157 the maturing phagosome (17, 18). The growth rate of ΔcydA was significantly reduced at low pH in comparison 
158 to H37Rv or the complemented mutant strain (Figure 3A-C). We next sought to determine if the IFNγ-
159 dependent acidification of the phagosome in macrophages could account for the intracellular growth defect of 
160 the ∆cydA mutant.  BMDMs from wildtype, Nos2-/- and Cybb-/- mice were infected with either H37Rv or the 
161 ∆cydA mutant, and we determined if the inhibitory effect of IFNγ was affected with bafilomycin A1, an inhibitor 
162 of the vacuolar-type H+-ATPase that is responsible for the acidification of the phagosome.  Using the live/dead 
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163 reporter assay, we confirmed that Nos2 was required for IFNγ to inhibit H37Rv, but not the ∆cydA mutant, 
164 providing a situation where the NO-independent inhibitory effect of IFNγ on bd oxidase-deficient Mtb could be 
165 assessed.  In these Nos2-/- macrophages, BAF had no effect on the growth of H37Rv, but completely reversed 
166 the inhibitory effect of IFNγ on the ∆cydA mutant, restoring fitness to levels equivalent to unstimulated BMDMs 
167 (Figure 3D). In all three macrophage genotypes, BAF treatment restored the fitness of the ∆cydA mutant to 
168 wild type levels in the presence of IFNγ.  While BAF treatment had a modest effect on the fitness of wild type 
169 Mtb, the preferential effect on the ∆cydA mutant was consistent with the hypersensitivity of this strain to low 
170 pH.  Together these observations indicate that the NO-independent inhibitory effect of IFNγ on bd oxidase-
171 deficient Mtb could primarily be attributed to the lowered pH of the phagosome.
172 The bd oxidase is necessary for optimal respiration under low pH conditions  
173 Next, we hypothesized that the fitness defect of the ΔcydA at low pH was due to reduced activity of the 
174 remaining cytochrome bc1/aa3 under these conditions. To evaluate OXPHOS in H37Rv and ΔcydA at low pH, 
175 we used extracellular flux analysis (Agilent Seahorse XFe96) to measure the oxygen consumption rate (OCR). 
176 There was no difference in OCR between H37Rv exposed to pH 7.4 and pH 4.5 media (prior to CCCP 
177 addition), suggesting that the respiratory chain in wildtype Mtb is able to adapt to reduced pH (Figure 4A). 
178 Q203 (Telacebec), an inhibitor of the QcrB subunit of the cytochrome bc1/aa3 complex (5), was used to 
179 specifically measure the acid sensitivity of cytochrome bd oxidase in H37Rv. At pH 7.4, consistent with 
180 previous studies, addition of Q203 led to increased OCR through the re-routing of electrons through 
181 cytochrome bd (6, 9) (Figure 4A). At pH 4.5, Q203-treated cells displayed an even higher OCR than at neutral 
182 pH, potentially indicating further inhibition of the cytochrome bc1/aa3 complex and increased reliance on 
183 cytochrome bd (Figure 4B). 
184 The same experiments were performed with the ΔcydA mutant to more specifically probe the effects of 
185 low pH on cytochrome bc1/aa3 (Figure 4C). First, we verified that Q203 abrogated OCR in the ∆cydAB strain, 
186 indicating that both terminal oxidases are inhibited under these conditions.  More importantly, decreasing the 
187 pH from 7.4 to 4.5 reduced OCR in the ΔcydA mutant strain (following media addition – green line and bar), 
188 where only the bc1/aa3 complex is active (Figure 4C and D).  As this decrease in OCR at low pH was seen only 
189 in the ∆cydAB mutant and not wild type (Figure 4A), these data indicate that cytochrome bc1/aa3 activity is 
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190 preferentially reduced under these conditions (Figure 4D). Given this pH-dependent decrease in activity, we 
191 hypothesized that acid stress would also increase the sensitivity of cytochrome bc1/aa3 to inhibition. Indeed, 
192 reducing the pH from 7.4 to 5.5 enhanced the potency of Q203, lowering the MIC50 by almost 20-fold (Figure 
193 4E). In sum, we observed that low pH both decreases bc1/aa3-dependent OCR and increases the potency of a 
194 bc1/aa3-specific inhibitor.  These findings indicate that cytochrome bc1/aa3 activity is inhibited at low pH, and 
195 that the cytochrome bd oxidase is preferentially required to maintain respiration under acidic conditions, such 
196 as those found in the phagosome of IFNγ-stimulated macrophages.  
197 Discussion  
198 The flexibility of bacterial respiratory chains facilitates adaptation to changing environments, and in 
199 many situations the bd oxidase becomes critical under conditions where the bc1/aa3 complex is inhibited.  In 
200 pathogens such as E.coli, Listeria monocytogenes, and Salmonella typhimuirium, the requirement for the 
201 cytochrome bd oxidase in bacterial virulence has been attributed to its role in resisting hypoxia and nitrosative 
202 and oxidative stress (23-26). While previous studies in M. marinum and M. smegmatis found that the 
203 mycobacterial bd oxidase can also confer resistance to hypoxia and peroxide, the specific roles played by the 
204 cytochrome bd and bc1/aa3 oxidases of Mtb during infection has been less clear.  Our work indicates that the 
205 flexibility of the Mtb respiratory chain facilitates adaptation to changes in the immune response.  As outlined 
206 below, our findings specifically suggest that the cytochrome bd oxidase provides resistance to IFNγ-mediated 
207 immunity by facilitating respiration under the acidic conditions encountered in the phagosomes of IFNγ-
208 stimulated macrophages.  
209 Both in ex vivo macrophage cultures and intact animals, we found that the bd oxidase was required to 
210 resist IFNγ-dependent immunity.  These data are consistent with those of Shi et al., who showed that Mtb 
211 cytochrome bd oxidase mutants were specifically attenuated in C57BL6 mice only after 50 days of infection. 
212 (14). Conversely, other studies have concluded that the cytochrome bd oxidase is dispensable for growth in 
213 C57BL/6J and BALB/C mice (2, 4). We suspect that these differing conclusions were caused by variations in 
214 the infection models.  Specifically, our study used a competitive infection model, which ensures that both wild 
215 type and mutant bacteria are exposed to identical immune pressures and captures even transient differences 
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216 in fitness.  As a result, we consider competitive studies, such as ours, to be a sensitive approach to detect 
217 differences in fitness.  
218 While IFNγ stimulation induces large transcriptional changes and antimycobacterial functions in 
219 macrophages, we attributed the bd oxidase requirement to alterations in phagosomal pH.  Nos2 and Phox are 
220 strongly induced by IFNγ, and the requirement for the bd oxidase in other bacterial pathogens has been 
221 attributed to the resulting NO and ROS (21).  As a result, it was somewhat surprising that the sensitivity of 
222 ∆cydA mutant bacteria to IFNγ treatment was independent of these mediators.  Instead, multiple lines of 
223 evidence indicated that this mutant was sensitive to the low pH encountered in the phagosome of IFNγ-
224 stimulated macrophages.  Firstly, we found that that bd oxidase-deficient bacteria grew poorly and respired at 
225 reduced rates at low pH.  These  findings that are consistent with previous transposon mutant screening data 
226 suggesting that the cydABDC operon was required for optimal growth at pH 4.5 (27). While the reduction in 
227 OCR that we observed in the ∆cydA mutant at low pH was modest, we speculate that even a small deficit in 
228 respiratory rate could cause the observed decrease in growth.  These in vitro growth defects were related to 
229 the intracellular growth environment by demonstrating that inhibition of vacuolar acidification with BAF 
230 abrogated the relative fitness difference between ∆cydA and wild type Mtb in IFNγ-stimulated macrophages.  
231 While these data are consistent with a primary role for the bd oxidase in adaptation to low pH conditions, we 
232 note that inhibition of phagosome acidification can have pleiotropic effects on processes such as phagosome-
233 lysosome fusion and autophagy.  Thus, while it remains possible that additional stresses play a role, our 
234 observations are consistent with a model in which the bd oxidase promotes resistance to the adaptive immune 
235 response by promoting respiration in the low pH environment of the IFNγ-stimulated macrophage.  
236 While the requirement for bd oxidase activity at low pH can be attributed to the reduced activity we 
237 detected for the bc1/aa3 complex under these conditions, the mechanism by which low pH inhibits the activity of 
238 the cytochrome bc1/aa3 is unclear. The cytochrome bc1/aa3 super complex is tightly coupled to the transport of 
239 protons (28). For every O2 molecule reduced by the super complex, 4 protons are pumped into the periplasm 
240 and contribute to the proton motive force (PMF) (28). While the cytochrome bd oxidase also contributes 
241 protons to PMF, it does not have proton pumping capabilities and contributes half of the protons for every 
242 molecular oxygen reduced as the super complex (7, 29). It is possible that the tight coupling between proton 
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243 pumping and electron transfer for the cytochrome bc1/aa3 complex results in its inhibition when extracellular 
244 proton concentrations are high. However, acid stress induces a wide variety of transcriptional and physiological 
245 responses in Mtb and it is also possible that pH has additional indirect effects on the cytochrome bc1/aa3 
246 complex (30-32). 
247 The success of bedaquiline, a mycobacterial ATPase inhibitor, has made respiration an attractive target 
248 for new therapeutics. Multiple small molecule inhibitor screens have identified drugs that target the QcrB 
249 component of the proton-pumping cytochrome bc1/aa3 (3, 5, 33, 34). Most notably is Q203 (Telacebec) which 
250 is currently in clinical trials (5). However, the flexibility of the mycobacterial respiratory chain has raised 
251 concerns about the potential efficacy of this drug (2, 4, 35).  One strategy to enhance the efficacy of respiratory 
252 inhibition is to simultaneously target both the bc1/aa3 and bd oxidase complexes, which produces a bactericidal 
253 effect (4, 6, 9). Our data suggest that immunity is another important factor that determines the relative 
254 importance of terminal oxidases and the ultimate efficacy of these agents.  The concept is similar to the 
255 previously described synergy between IFNγ-induced tryptophan depletion and the efficacy of Mtb tryptophan 
256 synthesis inhibitors (27). These examples highlight the importance of understanding the interactions between 
257 bacterial physiology and immunity for evaluating and optimizing new therapies.  
258
259 Experimental Methods 
260 Bacterial growth and strain generation 
261 Mycobacterium tuberculosis strains were cultured at 37°C in complete Middlebrook 7H9 medium containing oleic 
262 acid-albumin-dextrose-catalase (OADC, Becton, Dickinson), 0.2% glycerol, and 0.05% Tween 80 or 0.02% 
263 Tyloxapol. Hygromycin, kanamycin, and zeocin were add as necessary at 50 ug/mL, 25 ug/mL, and 25 ug/mL, 
264 respectively.  All Mtb mutant strains were derived from the wildtype H37Rv. ΔcydA, ΔcydD and ΔcydABDC 
265 operon were deleted by allelic exchange as described previously (19). The gene deletions were confirmed by 
266 PCR verification and sequencing of the 5’ and 3’ recombinant junctions and the absence of an internal fragment 
267 within the deleted region. An L5attP-zeoR-cydABDC-operon complementing plasmid was assembled by 
268 Gateway reaction (Invitrogen) and transformed into the hygR cydA mutant to generate the cydABDC-
269 complementing strain. The Live/Dead reporter strains were generated by transforming Mtb with the replicating 
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270 Live/Dead plasmid that contains a constitutively expressed GFP and a tetracycline-inducible TagRFP fluorescent 
271 protein. 
272 Ethics Statement and Experimental Animals 
273 C57BL/6 (stock no. 000664), Cybb-/- (B6.129S-Cybbtm1Din/J stock no. 002365), Nos2-/-(B6.129P2-Nos2tm1Lau/J, 
274 stock no. 002609),  Ifngr-/- (B6.129S7-Ifngr1tm1Agt/J), and Rag-/- (B6.129S7-Rag1tm1Mom/J, stock no. 002216) were 
275 purchased from the Jackson Laboratory. Housing and experimentation were in accordance with the guidelines 
276 set forth by the Department of Animal Medicine and University of Massachusetts Medical School Institutional 
277 Animal Care and Use Committee (IACUC). Animals used for experimentation were between 6 and 8 weeks old. 
278 Macrophage infection 
279 Bone marrow derived macrophages (BMDMs) were isolated from C57BL/6, Cybb−/− or Nos2−/− mice by 
280 culturing bone marrow cells in DMEM supplemented with 20% conditioned medium from L929, 10% FBS, 2 
281 mM L-glutamine and 1 mM sodium pyruvate for 7 days. BMDMs were seeded and left unstimulated or 
282 stimulated with IFN-γ (25ng/mL, PeproTech) overnight and then infected with Mtb at an MOI of 5.  After 4 h 
283 incubation, macrophages were washed twice with PBS to remove extracellular bacteria and incubated in fresh 
284 complete medium with or without IFN-γ. In some conditions, bafilomycin A (100ng/mL, Sigma) or Q203 (at 
285 specified concentrations) was added. Cells were lysed with 1% Saponin/PBS (Sigma) at 120 h after infection 
286 and then plated on 7H10-OADC plates in serial dilutions. CFUs were counted after 3 weeks of incubation at 
287 37°C. 
288 Flow Cytometry 
289 For flow cytometry, BMDMs pretreated with or without IFN-γ were infected with Live/Dead reporter Mtb strains. 
290 At day 3 post-infection, tetracycline (500 ng/ml) was added to medium. Macrophages were harvested after 24 
291 hours tetracycline addition and fixed with 4% PFA for 45 minutes, then run on an LSR II flow cytometer.
292 Mouse Infection 
293 Prior to infection, Mtb strains were resuspended and sonicated in PBS containing 0.05% Tween80. ΔcydA 
294 mutant fitness in vivo was determined by inoculating mice with a ~1:1 mixture of ΔcydA (hygromycin resistant) 
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295 and H37Rv (harboring pJEB402 chromosomally integrated plasmid encoding kanamycin resistance) strains via 
296 the respiratory route using an aerosol generation device (Glas-Col). At the indicated time points, mice were 
297 sacrificed and CFU numbers in lung homogenate were determined by plating on 7H10-OADC agar containing 
298 Kanamycin (25 ug/mL) or Hygromycin (50 ug/mL). 
299 Acid sensitivity assays. 
300 The early log-phase of Mtb strains were wash twice with PBS and inoculated to a starting optical density at 600 
301 nm (OD600) of 0.01 in 96-well plates with 7H9-Tyloxapol-7.4, 7H9-Ty-6.0, 7H9-Ty-5.5, 7H9-Ty-5.0 and 7H9-Ty-
302 4.5, respectively. The desired media pH was achieved by adding 2.5N HCl and 1N NaOH. In some conditions, 
303 Q203 (gifted from Professor Barry Clifton) was added. Growth was monitored by OD600 daily. Growth rate was 
304 determined by comparing OD600 under different pH in day 5. 
305 Extracellular Flux Analysis
306 The OCR of Mtb bacilli adhered to the bottom of an XF cell culture microplate (Cell-Tak coated) (Seahorse 
307 Biosciences), at 2x106 bacilli per well, were measured using a XF96 Extracellular Flux Analyser (Seahorse 
308 Biosciences)(6). All XF assays were carried out in unbuffered 7H9 media (pH 7.4 or pH 4.5 for acidic 
309 conditions) without a carbon source.  Basal OCR was measured for ~ 25 min before the addition of compounds 
310 through the drug ports of the sensor cartridge.  After media or Q203 addition (0.9 µM), OCR was measured for 
311 ~ 40 min, followed by the addition of the uncoupler carbonyl cyanide m-chlorophenyl hydrazone (CCCP) (2 
312 µM) and the OCR measured for a further ~20 min.  All OCR Figures indicate the approximate point of each 
313 addition as dotted lines.  OCR data points are representative of the average OCR during 4 min of continuous 
314 measurement in the transient microchamber, with the error being calculated from the OCR measurements 
315 taken from at least three replicate wells by the Wave Desktop 2.2 software (Seahorse Biosciences).  The 
316 microchamber is automatically re-equilibrated between measurements through the up and down mixing of the 
317 probes in the wells of the XF cell culture microplate.
318 MIC assay
319 Log-phase H37Rv was washed twice with PBS + 0.02% tyloxapol and used to inoculate 10mL cultures of 7H9-
320 Ty-7.0, 7H9-Ty-6.5, and 7H9-Ty-5.5 to an OD600 of 0.02. As stated before, media pH was achieved by the 
321 addition of 2.5N HCl or 1N NaOH. To determine the MIC of Q203 (HY-101040, MedChemExpress), 3-fold serial 
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322 dilutions from 24nM to 0.3 nM were performed at pH 7.0, 6.5, and 5.5 with a vehicle (DMSO) control. Cultures 
323 were incubated at 37°C with shaking. The Syngery HXT microplate reader was used to measure daily OD600 of 
324 100uL aliquots in a 96 well plate. The MIC values were calculated on day 6 of growth using nonlinear regression 
325 analysis. 
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452 Figures
453 Figure 1: ΔcydA mutant is susceptible to IFNγ-activation of macrophages independent of iNOS and 
454 Phox 
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464
465 Figure 1: cydA is required to resist IFNγ-mediate immunity independent of Nos2 and Phox.  A) Growth 
466 curve of H37Rv and ΔcydA  grown in broth for 12 days. B) C57BL/6J (WT), Nos2-/- and Cybb-/- BMDMs were 
467 left untreated or treated with 25ng/mL of IFNγ for 18 h. Macrophages were infected with H37Rv (solid)  or 
468 ΔcydA (diagonal bars) live-dead reporter strains (MOI=5). Y-axis represents the fraction BMDMs with live 
469 bacteria (RFP+GFP+) over total infected BMDMs (GFP+) determined by flow cytometry. C) IFNγ treated or 
470 untreated BMDMs were infected (MOI=5) with H37Rv (solid) or ΔcydA (diagonal bars). CFU determined 4 days 
471 post-infection. Represented as percent survival relative to untreated. D) IFNγ treated or untreated Nos2-/- 
472 BMDMs infected with H37Rv, ΔcydA, ΔcydD, ΔcydA:ΔcydABDC, or ΔcydD:ΔcydABDC (MOI=5). CFU 
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473 determined 4 days post-infection. Represented as percent survival relative to untreated. Analysis of B and C 
474 was preformed using a two-way ANOVA with Sidak post-test. Analysis of D was performed using a Dunnett’s 
475 multiple comparisons test (H37Rv stimulated versus other stimulated conditions). * p-value < 0.05, ** p-value < 
476 0.01, **** p-value <0.0001.
477 Figure 2: IFNγ but not iNOS or Phox is necessary for attenuation of ΔcydA mutants in mouse lungs
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504 on day 15 and day 30 post infection and dilutions of lung homogenates were plated on both 7H10+kanamycin 
505 and 7H10+hygromycin. B) Colony forming units (CFU) of H37Rv (black) and ΔcydA (open) in the lungs of 
506 C57BL/6J (WT), Nos2-/-, Cybb-/-, Ifngr-/-, and Rag-/- mice were enumerated at day 15 and day 30 post-
507 infection. C) ΔcydA mutant can be complemented in vivo in C57BL/6J. Lung CFU of H37Rv and ΔcydA:ABDC 
508 shown at day 15 and day 30 post-infection. 
509 Figure 3: ΔcydA are defective for growth at low pH
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526 7H9-tyloxapol at pH 7.4, pH 6.0, pH 5.5, pH 5.0, and pH 4.5 measured by OD600 for 5 days in a 96 well plate. 
527 C) ΔcydA mutant is complemented (ΔcydA:ABDC) at pH 6.2. Cultures grown for 7 days in inkwells. D) WT, 
528 Nos2-/- and Cybb-/- BMDMs were left untreated or treated with IFNγ (25ng/mL). Macrophages were infected 
529 with H37Rv (solid) or ΔcydA (diagonal bars) live-dead reporter strains (MOI=5). Post-infection BMDMs were 
530 left untreated, treated with IFNγ, or treated with IFNγ and Bafilomycin A (100ng/mL). The fraction of 
531 macrophages harboring live bacteria (%Live/ Live+Dead) was determined using flow cytometry. Analysis of C 
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532 was performed using a one-way ANOVA. Analysis of D was performed using a two-way ANOVE with Sidak 
533 post-test.  Dunnett’s. * p-value < 0.05, ** p-value < 0.01, **** p-value <0.0001
534
535 Figure 4: Low pH alters bacterial oxygen consumption rate in Q203 treated WT and ΔcydAB strains 
536
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562 Figure 4: Low pH reduces cytochrome bc1/aa3  dependent oxygen consumption. A) H37Rv was exposed 
563 to media at pH 7.4 and pH 4.5 for ~30 minutes and then treated with Q203 (10nM), followed by the uncoupler, 
564 CCCP. The oxygen consumption rate (OCR) was measured using the extracellular flux analyser B) Bar graphs 
565 are plotted from point 9 (indicated by the black arrow in A) before the addition of CCCP. C) ΔcydAB mutant 
566 was exposed to the same conditions described in A. D) Bar graph of point 9 (black arrow in C). E) IC50 curves 
567 of H37Rv treated with Q203 at pH 7.0, pH 6.5 and pH 5.5- day 6. IC50 values for Q203 (nM) at each pH show 
568 in the table.  
569
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